The 1-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as antidepression medicine thereof

Details for Australian Patent Application No. 2009301530 (hide)

Owner Shanghai Institute of Phamaceutical In- dustry CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.

Inventors Li, Jianqi; Lv, Na; Jin, Hua; Weng, Zhijie; Zheng, Yongyong

Agent Spruson & Ferguson

Pub. Number AU-A-2009301530

PCT Pub. Number WO2010/040315

Priority 200810043821.8 07.10.08 CN

Filing date 29 September 2009

Wipo publication date 15 April 2010

International Classifications

C07D 295/084 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/040315 Priority application(s): WO2010/040315

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009301560-Method for detection of analyte in microarray of samples and apparatus for performing such method

2009301517-Methods for isolating mesenchymal stem cells from embryos of human or animals and extracting secretion substances thereof